Long-term response of vulvar mucosal melanoma treated with neoadjuvant nivolumab.

Dubus, Margaux; Charles, Julie; Leccia, Marie-Thérèse; Mouret, Stéphane; Trabelsi, Sabiha

Dubus, Margaux; Charles, Julie; Leccia, Marie-Thérèse; Mouret, Stéphane; Trabelsi, Sabiha.

Afiliación

Dubus M; Dermatology Department, Grenoble Alpes University Hospital, La Tronche, France.
Charles J; Dermatology Department, Grenoble Alpes University Hospital, La Tronche, France.
Leccia MT; Dermatology Department, Grenoble Alpes University Hospital, La Tronche, France.
Mouret S; Dermatology Department, Grenoble Alpes University Hospital, La Tronche, France.
Trabelsi S; Dermatology Department, Grenoble Alpes University Hospital, La Tronche, France.

JAAD Case Rep ; 38: 14-16, 2023 Aug.

Article en En | MEDLINE | ID: mdl-37600735

Palabras clave

immune checkpoint inhibitors; immunotherapy; melanoma; neoadjuvant therapy; nivolumab; vulvar neoplasms

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: JAAD Case Rep Año: 2023 Tipo del documento: Article País de afiliación: Francia

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google